Abstract
Sleep disorders are very prevalent in Parkinson’s disease (PD) and include a diversity of disturbances. Rating scales and questionnaires are widely used to assess the presence and severity of the sleep disorders. The objective is to review rating scales and questionnaires used for assessment of sleep disorders in PD. To this purpose, a description and update of the sleep scales reviewed by the ad hoc Movement Disorder Society task force (MDS-TF) and other sleep disorder assessments was performed. Two specific (Parkinson’s Disease Sleep Scale and Scales for Outcomes in PD Sleep) and two generic scales (Pittsburgh Sleep Quality Index and Epworth Sleepiness Scale) were “Recommended” by the MDS-TF as they were used in PD patients, by researchers others than their developers and properly validated. Two other generic scales (Inappropriate Sleep Composite Score and Stanford Sleepiness Scale), “Suggested” due to incomplete validation, are also reviewed. Other instruments included in this review are three comprehensive PD-specific instruments for assessing multiple domains in addition to sleep problems (e.g., Non-Motor Symptoms Questionnaire, Non-Motor Symptoms Scale, MDS-UPDRS), and three generic instruments focused on particular disturbances (e.g., International Restless Legs Syndrome Study Group Rating Scale, REM behavioral disorders questionnaires), although these latter lack formal validation in PD populations. The “Recommended” instruments cover satisfactorily the needs for screening and evaluation of the nocturnal sleep disorders and daytime sleepiness in PD patients. It would be convenient to validate or complete the validation in PD populations of those instruments that cannot be recommended due to the lack of information on their clinimetric attributes.
Similar content being viewed by others
References
Abe K, Hikita T, Sakoda S (2005) Sleep disturbances in Japanese patients with Parkinson’s disease—comparing with patients in the UK. J Neurol Sci 234:73–78
Arnulf I (2005) Excessive daytime sleepiness in Parkinsonism. Sleep Med Rev 9:185–200
Askenasy JJM, Mendelsohn L, Katz A (1985) Basal ganglia disorders with marked circadian fluctuations. Sleep Res 14:142
Backhaus J, Junghanns K, Broocks A, Riemann D, Hohagen F (2002) Test–retest reliability and validity of the Pittsburgh sleep quality index in primary insomnia. J Psychosom Res 53:737–740
Boddy F, Rowan EN, Lett D, O`Brien JT, McKeith IG, Burn DJ (2007) Subjectively reported sleep quality and excessive daytime somnolence in Parkinson’s disease with and without dementia, dementia with lewy bodies and Alzheimer’s disease. Int J Geriatr Psychiatry 22:529–535
Borek LL, Kohn R, Friedman JH (2006) Mood and sleep in Parkinson’s disease. J Clin Psychiatry 67:958–963
Brodsky MA, Godbold J, Roth T, Olanow CW (2003) Sleepiness in Parkinson’s disease: a controlled study. Mov Disord 18:668–672
Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193–213
Carpenter JS, Andrykowski MA (1998) Psychometric evaluation of the Pittsburgh sleep quality index. J Psychosom Res 45:5–13
Chahine LM, Daley J, Horn S et al (2013) Questionnaire-based diagnosis of REM sleep behavior disorder in Parkinson’s disease. Mov Disord 28:1146–1149
Chaudhuri KR, Pal S, DiMarco A et al (2002) The Parkinson’s disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson’s disease. J Neurol Neurosurg Psychiatr 73:629–635
Chaudhuri KR, Martinez-Martin P, Schapira AHV et al (2006) International multicenter pilot study of the first comprehensive self-completed non-motor symptoms questionnaire for Parkinson’s disease: the NMSQuest study. Mov Disord 21:916–923
Chaudhuri KR, Martinez-Martin P, Brown RG et al (2007) The metric properties of a novel non-motor symptoms scale for Parkinson’s disease: results from an international pilot study. Mov Disord 22:1901–1911
Chaudhuri KR, Martinez-Martin P, Rolfe KA et al (2012) Improvements in nocturnal symptoms with ropinirole prolonged release in patients with advanced Parkinson’s disease. Eur J Neurol 19:105–113
Cole JC, Motivala SJ, Buysse DJ, Oxman MN, Levin MJ, Irwin MR (2006) Validation of a 3-factor scoring model for the Pittsburgh sleep quality index in older adults. Sleep 29:112–116
de Oerlemans WG, Weerd AW (2002) The prevalence of sleep disorders in patients with Parkinson’s disease: a self-reported, community-based survey. Sleep Med 3:147–149
Dhawan V, Dhoat S, Williams AJ et al (2006) The range and nature of sleep dysfunction in untreated Parkinson’s disease (PD): a comparative controlled clinical study using the Parkinson’s disease sleep scale and selective polysomnography. J Neurol Sci 248:158–162
Dowling GA, Mastick J, Colling E, Carter JH, Singer CM, Aminoff MJ (2005) Melatonin for sleep disturbances in Parkinson’s disease. Sleep Med 6:459–466
Factor SA, McAlerney T, Sánchez-Ramos JR, Weiner WJ (1990) Sleep disorders and sleep effect in Parkinson’s disease. Mov Disorrd 5:280–285
Gagnon JF, Berdard MA, Fantini ML (2002) REM sleep behavior disorder and REM sleep without atonia in Parkinson’s disease. Neurology 59:585–589
García-Borreguero D, Larrosa O, Bravo M (2003) Parkinson’s disease and sleep. Sleep Med Rev 7:115–129
Goetz CG, Wuu J, Curgian LM, Leurgans S (2005) Hallucinations and sleep disorders in PD: six-year prospective longitudinal study. Neurology 64:81–86
Hagell P, Broman J-E (2007) Measurement properties and hierarchical item structure of the Epworth sleepiness scale in Parkinson’s disease. J Sleep Res 16:102–109
Hobson DE, Lang AE, Martin WR et al (2002) Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian movement disorders group. JAMA 287:455–463
Högl BE, Gomez-Arevalo G, Garcia S et al (1998) A clinical, pharmacologic, and polysomnographic asyudy of sleep benefit in Parkinson’s disease. Neurology 50:1332–1339
Högl B, Arnulf I, Comella C et al (2010) Scales to assess sleep impairment in Parkinson’s disease: critique and recommendations. Mov Disord 25:2704–2716
Homann CN, Wenzel K, Suppan K, Ivanic G, Crevenna R, Ott E (2003) Sleep attacks-facts and fiction: a critical review. Adv Neurol 91:335–341
Honig H, Antonini A, Martinez-Martin P et al (2009) Intrajejunal levodopa infusion in Parkinson’s disease: a pilot multicenter study of effects on non-motor symptoms and quality of life. Mov Disord 24:1468–1474
Iranzo A, Valldeoriola F, Santamaria J, Tolosa E, Rumia J (2002) Sleep symptoms and polysomnographic architecture in advanced Parkinson’s disease after chronic bilateral subthalamic stimulation. J Neurol Neurosurg Psychiatry 72:661–664
Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14:540–545
Juri C, Chana P, Tapia J, Kunstmann C, Parrao T (2005) Quetiapine for insomnia in Parkinson disease: results from an open-label trial. Clin Neuropharmacol 28:185–187
Kales A, Ansel RD, Markham CH, Scharf MB, Tan TL (1971) Sleep in patients with Parkinson’s disease and normal subjects prior to and following levodopa administration. Clin Pharmacol Ther 12:397–406
Kumar S, Bhatia M, Behari M (2003) Excessive daytime sleepiness in Parkinson’s disease as assessed by Epworth sleepiness scale. Sleep Med 4:339–342
Lees AJ, Blackburn NA, Campbell VL (1988) The nighttime problems of Parkinson’s disease. Clin Neuropharmacol 11:512–519
Lowe AD (1998) Sleep in Parkinson’s disease. J Psychosom Res 44:613–617
Margis R, Donis K, Schonwald SV et al (2009) Psychometric properties of the Parkinson’s disease sleep scale—Brazilian version. Parkinsonism Relat Disord. 15:495–499
Maria B, Sophia S, Michalis M et al (2003) Sleep breathing disorders in patients with idiopathic Parkinson’s disease. Respir Med 97:1151–1157
Marinus J, Visser M, Van Hilten JJ, Lammers GJ, Stiggelbout AM (2003) Assessment of sleep and sleepiness in Parkinson disease. Sleep 26:1049–1054
Martinez-Martin P, Salvador C, Menendez-Guisasola L et al (2004) Parkinson’s disease sleep scale: validation study of a Spanish version. Mov Disord 19:1226–1232
Martinez-Martin P, Cubo E, Aguilar M et al (2006) A pilot study on a specific measure for sleep disorders in Parkinson’s disease: SCOPA-Sleep. Rev Neurol 43:577–583
Martinez-Martin P, Visser M, Rodriguez-Blazquez C et al (2008) SCOPA-sleep and PDSS: two scales for assessment of sleep disorder in Parkinson’s disease. Mov Disord 23:1681–1688
Martinez-Martin P, Reddy P, Antonini A et al (2011) Chronic subcutaneous infusion therapy with apomorphine in advanced Parkinson’s disease compared to conventional therapy: a real life study of non motor effect. J Parkinson Dis 1:197–203
Martinez-Martin P, Falup Pecurariu C, Odin P et al (2012) Gender-related differences in the burden of non-motor symptoms in Parkinson’s disease. J Neurol 259:1639–1647
Monaca C, Duhamel A, Jacquesson JM et al (2006) Vigilance troubles in Parkinson’s disease: a subjective and objective polysomnographic study. Sleep Med 7:448–453
Mouret J (1975) Differences in sleep in patientswith Parkinson’s disease. Electroencephalogr Clin Neurophysiol 38:637–673
Nausieda PA, Weiner WJ, Kaplan LR, Klawans HL (1982) Sleep disruption in course of chronic levodopa therapy: an early feature of the levodopa psychosis. Clin Neuropharmacol 5:183–194
Nomura T, Inoue Y, Kagimura T, Uemura Y, Nakashima K (2011) Utility of the REM sleep behavior disorder screening questionnaire (RBDSQ) in Parkinson’s disease patients. Sleep Med 12:711–713
Ondo WG, Dat Vuong K, Khan H, Atassi F, Kwak C, Jankovic J (2001) Daytime sleepiness and other sleep disorders in Parkinson’s disease. Neurology 57:1392–1396
Ondo WG, Dat Vuong K, Jankovic J (2002) Exploring the relationship between Parkinson disease and restless legs syndrome. Arch Neurol 59:421–424
Pal PK, Thennarasu K, Fleming J, Schulzer M, Brown T, Calne SM (2004) Nocturnal sleep disturbances and daytime dysfunction in patients with Parkinson’s disease and in their caregivers. Parkinsonism Relat Disord 10:157–168
Parkinson J (2002) An assay on the shaking palsy [reprint of monograph published by Sherwood, Neely, and Jones, London, 1817]. J Neuropsychiatry Clin Neurosci 14:223–236
Paus S, Brecht HM, Koster J, Seeger G, Klockgether T, Wullner U (2003) Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson’s disease. Mov Disord 18:659–667
Pellecchia MT, Antonini A, Bonuccelli U et al (2012) Observational study of sleep-related disorders in Italian patients with Parkinson’s disease: usefulness of the Italian version of Parkinson’s disease sleep scale. Neurol Sci 33:689–694
Poewe W, Högl B (2000) Parkinson’s disease and sleep. Curr Opin Neurol 13:423–426
Poryazova R, Oberholzer M, Baumann CR, Basetti CL (2013) REM sleep behavior disorder in Parkinson’s disease: a questionnaire-based survey. J Clin Sleep Med 9:55–59
Postuma RB, Arnulf I, Högl B et al (2012) A single-question screen for rapid eye movement sleep behavior disorder: a multicenter validation study. Mov Disord 27:913–916
Seppi K, Hogl B, Diem A, Peralta C, Wenning GK, Poewe W (2006) Levodopa-induced sleepiness in the Parkinson variant of multiple system atrophy. Mov Disord 21:1281–1283
Setthawatcharawanich S, Limapichat K, Sathirapanya P, Phabphal K (2011) Validation of the Thai SCOPA-sleep scale for assessment of sleep and sleepiness in patients with Parkinson’s disease. J Med Assoc Thai 94:179–184
Sharf B, Moskovitz C, Lupton MD et al (1978) Dream phenomena induced by chronic levodopa therapy. J Neural Trasm 43:143–151
Smith MC, Ellgring H, Oertel WH (1997) Sleep disturbances in Parkinson’s disease patients and spouses. J Am Geriatr Soc 45:194–199
Stavitsky K, Saurman JL, McNamara P, Cronin-Golomb A (2010) Sleep in Parkinson’s disease: a comparison of actigraphy and subjective measures. Parkinsonism Relat Disord 16:280–283
Stiasny-Kolster K, Mayer G, Schäfer S et al (2007) The REM sleep behavior disorders screening questionnaire: a new diagnostic instrument. Mov Disord 22:2386–2393
Stocchi F, Vacca L, Valente M, Ruggieri S (2001) Sleep disorders in Parkinson’s disease. Adv Neurol 86:289–293
Svensson E, Beiske AG, Loge JH, Beiske KK, Sivertsen B (2012) Sleep problems in Parkinson’s disease: a community-based study in Norway. BMC Neurol 12:71
Tandberg E, Larsen JP, Karlsen K (1998) A community-based study of sleep disorders in patients with Parkinson’s disease. Mov Disord 13:895–899
Tandberg E, Larsen JP, Karlsen K (1999) Excessive daytime sleepiness and sleep benefit in Pakinson’s disease: a community-based study. Mov Disord 14:922–927
Todorova A, Martinez-Martin P, Martin A et al (2013) Daytime apomorphine infusion combined with transdermal rotigotine patch therapy: a 24 hours treatment option in Parkinson’s disease. Basal Ganglia 3:127–130
Trenkwalder C, Kies B, Rudzinska M et al (2011a) Rotigotine effects on early morning motor function and sleep in Parkinsons’ disease: a double-blind, randomized, placebo-controlled study (RECOVER). Mov Disord 26:90–99
Trenkwalder C, Kohnen R, Hogl B et al (2011b) Parkinson’s disease sleep scale—validation of the revised version PDSS-2. Mov Disord 26:644–652
Uemura Y, Nomura T, Inoue Y et al (2009) Validation of the Parkinson’s disease sleep scale in Japanese patients: a comparison study using the Pittsburgh sleep quality index, the Epworth sleepiness scale and polysomnography. J Neurol Sci 287:36–40
Van Hilten JJ, Weggeman M, van der Welede EA, Roos RAC (1993) Sleep, excessive daytime slepimess and fatigue in Parkinson’s disease. J. Neural Transm (D-P Sect) 5:235–244
Walters AS, LeBrocq C, Dhar A, Hening W, International Restless Legs Syndrome Study Group (2003) Validation of the restless legs syndrome study group rating scale for restless legs syndrome. Sleep Med 4(121):32
Wang G, Cheng Q, Zeng J et al (2008) Sleep disorders in Chinese patients with Parkinson’s disease: validation study of a Chinese version of Parkinson’s disease sleep scale. J Neurol Sci 271:153–157
Wetter TH, Collado-Seidel V, Pollmächer T, Yassouridis A, Trenkwalder C (2000) Sleep and periodic leg movement patterns in drug-free patients with Parkinson and multiple system atrophy. Sleep 23:361–367
Zibetti M, Rizzone M, Merola A et al (2013) Sleep improvement with levodopa/carbidopa intestinal gel infusion in Parkinson’s disease. Acta Neurol Scand 127:e28–e32
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zea-Sevilla, M.A., Martínez-Martín, P. Rating scales and questionnaires for assessment of sleep disorders in Parkinson’s disease: what they inform about?. J Neural Transm 121 (Suppl 1), 33–40 (2014). https://doi.org/10.1007/s00702-014-1217-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-014-1217-z